Keywords
Babesia, tick-borne disease, epidemiology, public health, bibliometric
This article is included in the Emerging Diseases and Outbreaks gateway.
Babesia, tick-borne disease, epidemiology, public health, bibliometric
Babesiosis is a zoonotic disease with a global distribution; it is mainly transmitted by ticks of different genera (e.g. Rhipicephalus spp. and Dermacentor spp.) and diverse species1. It is caused by infection of the erythrocytes of mammals by Babesia species, which are Apicomplexa protozoa of the suborder Piroplasmidea and the family Babesiidae2. The vector role of ticks for these parasites was discovered by Smith and Kilbourne in 1893, who were the first to demonstrate its transmission3. The first case was described by Skaraballo and occurred in 1957 in Zagreb, Croatia4.
Human babesiosis is not under surveillance and notification in most countries, including those with autochthonous incidence vector-borne diseases. However, studies show that their vectors are widely distributed in tropical and subtropical areas3. Research is fundamental to better comprehending this disease. The relevance of bibliometric evaluations on emerging and reemerging disease has been previously described5–7 as they can contribute in the understanding on how the global scientific and health communities respond to outbreaks8. Herein, our objective was to use bibliometric approaches to analyze Babesia research.
A bibliometric evaluation was performed focusing on Babesia scientific bibliography. Six main databases were used for retrieving information: Science Citation Index Expanded (SCI-E), Scopus, Medline, LILACS, SciELO and Google Scholar.
For the search pipeline we used the following combination of key words (MeSH, Medical Subject Headings): “Babesia” AND “Latin America”, “Babesia” AND “Argentina”, “Babesia” AND “Colombia”, and this strategy was maintained including the name of each country as a keyword. Also, “Babesiosis” was used as a substitute of Babesia to increase the number of results. Regarding the type of publications, we decided to include original papers, review articles, case reports and editorials, which were further stratified according to publication year and the name and institution to which the main author was affiliated at the time of publishing. This analysis included results obtained up to December 1, 2018.
Data summaries for quantitative variables (number of articles, articles per country, articles per year or periods, citations and H index) were expressed as means and interquartile ranges (IQRs), and for qualitative variables proportions are reported.
Overall, 78,137 Babesia-associated items resulted from the initial screening of publications. From Google Scholar 62,100 articles (25% USA, 24.9% South Africa, 18.5% Japan) were recovered, followed by Scopus, with 6,272 articles (25.4% from USA, 8.5% Japan, 7.2% UK), and Medline with 5.045 articles (13.7% USA, 10.1% Japan and 5.2% China) (Table 1). From Web of Science, 4,330 publications were retrieved (28.06% from USA, 11.4% Japan and 7.37% Brazil), followed by LILACS with 202 articles (29.2% Brazil, 2.4% Mexico, 1.9% USA) and SciELO with 188 articles (26.6% Brazil, 3.1% Mexico) (Table 1). Considering the Medline database, the number of research articles on Babesia increased above 100 publications per year only after 2004 (Figure 1).
In the case of Scopus, the median number of articles published each year as of 1970 was only one (IQR: 0-3), from 1970 until 1995 this number increased to 64 (IQR: 56-73) and from 1996 till 2018 was 188 (IQR: 115–271) (Figure 2). At Scopus 134 countries contributed a minimum of one paper over the study period. For SCI-E, the annual median number of articles reported from 1996 until 2018 was of 99 (IQR: 96-103) (Figure 3), with at least one article published from 129 countries during the study period.
“Obihiro University” in Hokkaido, Japan, was the institution with the most productive research in Scopus, and “Igarashi, I” was the author with the largest record in Babesia research, with 210 articles (Figure 4 and Figure 5). At Web of Sciences, the H index for the topic is 88, with 70,950 citations, reaching 7,734 citations in 2017 (Figure 6).
The results presented here show that the USA and Japan have primary roles in Babesia research, with USA leading the scientific production with nearly quarter of the published articles, followed by Japan and the UK (Table 1). Certainly, in USA, tickborne disease occurrence is frequent especially in certain areas and months over the year. Tickborne diseases such as babesiosis are commonly reported in Northeastern states as well in the upper Midwest, often with higher incidence in summer. In addition, blood transfusions is still a matter of concern, even in the USA10–13. In countries in Asia, such as Japan, human babesiosis was not reported until fairly recently (1999), when a symptomatic case was describe in Kobe City, Hyogo Prefecture, Japan14,15; however, since then research has significantly increased in this country. Authors from UK have collaborated with research with others from endemic countries. However, in 2006 and 2016, two cases of autochthonous canine babesiosis were reported in the UK. Since November 2015, there have been at least three more cases of canine babesiosis in untraveled dogs from Essex, all were confirmed B. canis infections by PCR. Dermacentor reticulatus ticks were found on the dogs16.
One of the relevant aspects surrounding babesiosis is that there are not yet licensed human prophylactic vaccines, and treatment alternative remain limited. Two commonly used antimicrobial regimes are highly effective: the combination of atovaquone and azithromycin and the combination of clindamycin and quinine17. Thus, most preventive measures are needed to reduce the risk of infection from ticks and wild and domestic reservoirs (e.g. rats).
Bibliometric analyses contribute an objective vision of the scientific activity of a country or a region, in an investigative area. In the particular case of infectious diseases, there are different reports about its utility5–8, especially in emerging infectious diseases18–20, being possible to establish and to compare the amount of scientific production in journals, institutions, and authors publishing about a certain issue; this would allow establishment of a plan in terms of scientific policy as well in other matters21. No previous bibliometric studies about babesiosis or Babesia have been found in the consulted bibliographical scientific databases.
In conclusion, it is time to translate research findings into effective control of babesiosis. As occurs with other emerging diseases, research leading to vaccinal or effective therapeutic options are of utmost importance. Tick-borne pathogens such as Babesia and others with even clearer epidemic potential need to be researched more and to be prioritized with effective interventions to reduce their negative impact.
Raw bibliometric data generated in this study are available on OSF. DOI: https://doi.org/10.17605/OSF.IO/ER9UP9.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
References
1. Gray J, Zintl A, Hildebrandt A, Hunfeld KP, et al.: Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity.Ticks Tick Borne Dis. 2010; 1 (1): 3-10 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Diagnostics on vector borne disease, neuropathology, surveillance program
Is the work clearly and accurately presented and does it cite the current literature?
No
Is the study design appropriate and is the work technically sound?
No
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Not applicable
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Parasitologist, with special interest in babesiosis and tick-borne diseases
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
References
1. Hernández-Vásquez A, Alarcon-Ruiz CA, Bendezu-Quispe G, Comandé D, et al.: A bibliometric analysis of the global research on biosimilars.J Pharm Policy Pract. 2018; 11: 6 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: Clinical and epídemiological research in Vector Borne Disease
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 2 (revision) 18 Jul 19 |
read | ||
Version 1 30 Dec 18 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)